Bio-Connect

SIRP alpha antibody [MRC OX-41] (FITC)

GTX76052
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry, RadioImmunoAssay
Product group Antibodies
ReactivityRat
TargetSirpa
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    SIRP alpha antibody [MRC OX-41] (FITC)
  • Delivery Days Customer
    9
  • Application Supplier Note
    For FACS: Use at an assay dependent dilution. For IF: Use at an assay dependetn dilution. For ICC: Use at an assay dependent dilution. For RIA (indirect): Use at an assay dependent dilution. Optimal dilutions/concentrations should be determined by the researcher.
  • Applications
    Flow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry, RadioImmunoAssay
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MRC OX-41
  • Concentration
    0.1 mg/ml
  • Conjugate
    FITC
  • Gene ID25528
  • Target name
    Sirpa
  • Target description
    signal-regulatory protein alpha
  • Target synonyms
    Bit; brain Ig-like molecule with tyrosine-based activation motifs; Brain immunoglobulin like protein with tyrosine - based activation motifs; CD172 antigen-like family member A; inhibitory receptor SHPS-1; macrophage fusion receptor; macrophage membrane protein MFP150; Protein tyrosine phosphatase, non-receptor type substrate 1 (SHP substrate 1); Ptpns1; SHP substrate 1; SHPS-1; signal-regulatory protein alpha-1; sirp-alpha-1; tyrosine-protein phosphatase non-receptor type substrate 1
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDP97710
  • Protein Name
    Tyrosine-protein phosphatase non-receptor type substrate 1
  • Scientific Description
    plays a role in macrophage fusion [RGD, Feb 2006]
  • Reactivity
    Rat
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Alloimmune activation promotes anti-cancer cytotoxicity after rat liver transplantation. Lacotte S et al., 2014, PLoS One
    Read more